Nobel Assembly announces Blackburn as co‑recipient of the 2009 Nobel Prize in Physiology or Medicine.
On 5 October 2009, the Nobel Assembly at Karolinska Institutet announced that Elizabeth H. Blackburn, Carol W. Greider, and Jack W. Szostak had been awarded the Nobel Prize in Physiology or Medicine "for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase." This decision formally recognized decades of pioneering work on chromosome ends and cellular aging.
The announcement highlighted Blackburn’s central role in elucidating the molecular structure of telomeres and, together with Greider, identifying telomerase, the enzyme that builds telomeric DNA. At a time when molecular biology was rapidly expanding, their discoveries solved a fundamental problem: how chromosomes can be fully replicated and protected from degradation during cell division.
Historically, this date is a barrier‑breaking milestone. Blackburn became the first Australian woman Nobel laureate, and the prize marked the first time two women shared a Nobel in a science category, challenging entrenched gender imbalances in elite scientific recognition. The announcement underscored the growing visibility of women scientists at the highest levels of research.
The legacy of the 5 October 2009 announcement reaches far beyond personal recognition. It propelled telomere and telomerase research into wider public awareness, stimulated new lines of inquiry in cancer, aging, and regenerative medicine, and provided a powerful narrative about persistence in basic research. For women in STEM globally, Blackburn’s Nobel announcement became a symbol of what was possible despite systemic barriers.